Atlas Trials

Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy

Clinical trial NCT01572597 · UNKNOWN

Trial details

NCT number
NCT01572597
Sponsor
Buddhist Tzu Chi General Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Start date
2011-06-01
Primary completion
2012-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.